Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.
Analyst Ratings
This is a breakdown of current ratings for Aveanna Healthcare and INVO Fertility, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aveanna Healthcare | 0 | 4 | 6 | 1 | 2.73 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
Aveanna Healthcare presently has a consensus price target of $14.25, indicating a potential upside of 6.70%. INVO Fertility has a consensus price target of $320.00, indicating a potential upside of 15,255.09%. Given INVO Fertility’s higher possible upside, analysts clearly believe INVO Fertility is more favorable than Aveanna Healthcare.
Risk and Volatility
Aveanna Healthcare has a beta of 2.03, meaning that its share price is 103% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.42, meaning that its share price is 142% more volatile than the S&P 500.
Insider and Institutional Ownership
88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 0.4% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Aveanna Healthcare and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aveanna Healthcare | 10.56% | 80.70% | 7.42% |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
Valuation & Earnings
This table compares Aveanna Healthcare and INVO Fertility”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aveanna Healthcare | $2.60 billion | 1.12 | $225.03 million | $1.23 | 10.86 |
| INVO Fertility | $6.84 million | 0.19 | -$25.13 million | ($33.83) | -0.06 |
Aveanna Healthcare has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.
Summary
Aveanna Healthcare beats INVO Fertility on 12 of the 14 factors compared between the two stocks.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
